Evidence map›Paper›PMID 42653461›Full record

ArticleInternational journal of molecular sciences2026

Proteomic Remodeling in Fontan Circulation Associated with Fibrosis and Time-Dependent Immune-Metabolic Alteration.

Isabel Mihajlovic, David Renaud, Alexander Kirchmair, Fatima Ageed, Bettina Sarg, Klaus Faserl, Dietmar Rieder, Alexander Blaha, Nele Ströbel, Christian Lechner and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Isabel MihajlovicDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0005-2230-443X
David RenaudDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0003-8746-5758
Alexander KirchmairBiocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-2284-7424
Fatima AgeedDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0008-8066-9658
Bettina SargBiocenter, Protein Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Klaus FaserlBiocenter, Protein Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-1646-3256
Dietmar RiederBiocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-1754-690X
Alexander BlahaDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0000-6086-3308
Nele StröbelDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Christian LechnerDepartment of Pediatrics, Division of Pediatric I-Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2720-1019
Kai Thorsten LaserDepartment for Children and Adults with Congenital Heart Disease (CHD), DOC Dortmund, Ruhr University Bochum, 44137 Dortmund, Germany.
Miriam MichelDepartment of Child and Adolescent Health, Division of Pediatrics III-Cardiology, Pulmonology, Allergology and Cystic Fibrosis, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-3626-3270

Funding

FWF Austrian Science Fund 10.55776/KLI1036
6 · The paper itself

Abstract

The Fontan circulation is associated with progressive multisystem complications, yet its underlying molecular mechanisms remain incompletely understood. We aimed to characterize systemic proteomic alterations and identify biological pathways associated with Fontan physiology, long-term adaptation, and clinically unfavorable phenotypes. Peripheral vein serum proteomics was performed using mass spectrometry in 48 Fontan patients and matched controls. Differential protein expression and pathway enrichment analyses were applied across the overall cohort and clinically defined subgroups according to Fontan duration and composite clinical risk phenotyping. More than one third of quantified proteins were differentially expressed, demonstrating extensive systemic proteomic remodeling. Extracellular matrix remodeling emerged as the dominant signature, characterized by fibrosis-associated proteins and enrichment of TGF-β-related profibrotic pathways. Prolonged Fontan duration and clinically unfavorable status were not associated with substantially amplified extracellular matrix signatures. Instead, long-term Fontan patients demonstrated increasing immune, complement, and endothelial activation, whereas high-risk patients showed metabolic and redox-related alterations. These findings indicate that extracellular matrix remodeling and profibrotic signaling are dominant features of the Fontan circulation, while increasing Fontan duration and clinical deterioration are associated with immune activation, endothelial stress, and metabolic dysregulation with oxidative stress.

Indexed as

Fontan ProcedureProteomeProteomicsChildExtracellular MatrixFemaleFibrosisHumansMaleTransforming Growth Factor betaProteomeTransforming Growth Factor betaendothelial dysfunctionextracellular matrixfibrosisFontan circulationimmune activationmetabolic remodelingproteomicsredox signalingTGF-β

Identifiers

PMID42653461
PMCPMC13513454

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.